J&J still plans to scale up Carvyk­ti man­u­fac­tur­ing this year as it awaits FDA de­ci­sion on ex­pan­sion to ear­li­er lines

John­son & John­son tout­ed “sig­nif­i­cant progress” in man­u­fac­tur­ing Carvyk­ti, the CAR-T ther­a­py it de­vel­oped with Leg­end Biotech, af­ter hav­ing to find ways to im­prove pro­duc­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER